Marty Felsenthal

Marty Felsenthal is a Partner at Health Velocity Capital based in San Francisco, California, where he focuses on growth equity investments in healthcare technology and services. At Health Velocity Capital, which manages over $1 billion in assets, he targets digital health and medtech companies, building a portfolio that includes Olive, CareCloud, and QGenda. Promoted to Partner in early 2023, he led a $100 million investment in a digital health platform in 2024 and speaks at industry events like the HLTH conference. Before his current role, Felsenthal served as a Managing Director at Deerfield Management and held investment positions at Versant Ventures and OrbiMed Advisors. He holds a Bachelor of Arts from Stanford University and a Master of Business Administration from Harvard Business School. His career centers on providing growth equity to founders scaling digital health and medical technology solutions.